HomeCompareLSIIF vs MRK

LSIIF vs MRK: Dividend Comparison 2026

LSIIF yields 0.77% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.0K in total portfolio value
10 years
LSIIF
LSIIF
● Live price
0.77%
Share price
$59.03
Annual div
$0.46
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.8K
Annual income
$81.48
Full LSIIF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — LSIIF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLSIIFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LSIIF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LSIIF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LSIIF
Annual income on $10K today (after 15% tax)
$65.86/yr
After 10yr DRIP, annual income (after tax)
$69.26/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,259.15/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LSIIF + MRK for your $10,000?

LSIIF: 50%MRK: 50%
100% MRK50/50100% LSIIF
Portfolio after 10yr
$38.8K
Annual income
$4,939.81/yr
Blended yield
12.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LSIIF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
3.6
Piotroski
9/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LSIIF buys
0
MRK buys
0
No recent congressional trades found for LSIIF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLSIIFMRK
Forward yield0.77%2.76%
Annual dividend / share$0.46$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$20.8K$56.8K
Annual income after 10y$81.48$9,798.13
Total dividends collected$796.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: LSIIF vs MRK ($10,000, DRIP)

YearLSIIF PortfolioLSIIF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,777$77.48$11,206$366.19$429.00MRK
2$11,610$78.04$12,650$502.35$1.0KMRK
3$12,501$78.57$14,407$694.19$1.9KMRK
4$13,455$79.07$16,585$967.82$3.1KMRK
5$14,477$79.53$19,342$1,363.89$4.9KMRK
6$15,570$79.97$22,913$1,947.19$7.3KMRK
7$16,740$80.39$27,662$2,823.89$10.9KMRK
8$17,993$80.77$34,159$4,173.35$16.2KMRK
9$19,334$81.14$43,337$6,308.80$24.0KMRK
10$20,769$81.48$56,776$9,798.13$36.0KMRK

LSIIF vs MRK: Complete Analysis 2026

LSIIFStock

Lisi S.A. provides assembly and component solutions for the aerospace, automotive, and medical industries in France and internationally. It operates through three divisions: LISI Aerospace, LISI Automotive, and LISI Medical. It offers titanium nuts, lightning strike protection, safety locks, and fuse pins; compressor blade and strut for the LEAP engine; LEAP engines composite fan blade leading edge; air intake lipskin for the airbus; power transmission semi-machined gears; stator vanes; and satellite antenna brackets for airplanes and helicopters. It also provides guide pins and electric parking brakes; braking systems and direct engine injections; screws and nuts; belt and seat mechanism products; special parts for motors and safety systems; clips for interior and exterior trim; assembly reduction and optimization solutions; and cable ducts. In addition, it offers assembly solutions, battery fastening systems, complex power transmission parts, and other automotive standard fasteners; clipped fastening systems for interior and exterior cladding, fasteners for tubes and cables, as well as solutions for weight reduction and optimizing assemblies; and covers components for braking, fluid management, and seat adjustment and interior safety systems. Further, it engages in the designing and modeling, prototypes, pre-series, materials, process validation, and replenishment of inventories; offers shoulders, reconstruction implants solutions for hips, knees, extremities, and instruments; blades, scissors, staplers, and pliers for surgery; and spinal and trauma implants, such as connectors, screws, cages, plates, and prostheses medical devices for treating trauma and osteosynthesis. The company was formerly known as GFI Industries and changed its name to LISI S.A. in 2002. The company was founded in 1777 and is headquartered in Belfort, France. Lisi S.A. operates as a subsidiary of Compagnie Industrielle De Delle S.A.

Full LSIIF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this LSIIF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LSIIF vs SCHDLSIIF vs JEPILSIIF vs OLSIIF vs KOLSIIF vs MAINLSIIF vs JNJLSIIF vs ABBVLSIIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.